日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficient (68)Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

利用非环状三(羟基吡啶酮)螯合剂对靶向B7-H3的亲和体分子进行高效的(68)Ga标记:对临床前模型中生物分布的影响

Tolmachev, Vladimir; Herlina, Amelinda Janice; Papalanis, Eleftherios; A Bezverkhniaia, Ekaterina; Ryer, Eva; Orlova, Anna; Y Frejd, Fredrik; Oroujeni, Maryam

HER2-targeted PET-imaging with [68Ga]Ga-ABY-025 to predict targeted-therapy response in HER2-expressing metastatic breast cancer: study protocol of a multicenter, prospective, open-label trial

使用 [68Ga]Ga-ABY-025 进行 HER2 靶向 PET 成像以预测 HER2 表达转移性乳腺癌的靶向治疗反应:一项多中心、前瞻性、开放标签试验的研究方案

Altena, Renske; Wiklander, Oscar P B; Romdhani, Nour Susaeg; Kistner, Anna; Klintman, Marie; Skarping, Ida; Lindman, Henrik; Rodriguez, Veronica Sanchez; Frisell, Oskar; Lindgren, Peter; Bratteby, Klas; Jussing, Emma; Feldwisch, Joachim; Frejd, Fredrik Y; Cascales, Helena Silva; Siikanen, Jonathan; Hindorf, Cecilia; Tran, Thuy A

Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer

对表达CD44v6的癌症进行基于抗体的伴随诊断的临床前评估

Oroujeni, Maryam; Selvaraju, Ram Kumar; Persson, Helena; Dahllund, Leif; Frejd, Fredrik Y; Mortensen, Anja C L

Preclinical Validation of [(177)Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials

CD44v6靶向放射性药物[(177)Lu]Lu-AKIR001的临床前验证,即将进入首次人体试验

Mortensen, Anja C L; Mohajershojai, Tabassom; Gustafsson, Amanda; Berglund, Hanna; Selvaraju, Ram Kumar; Hofström, Camilla; Persson, Helena; Ohlin, Mats; Tran, Thuy A; Morén, Anton Forsberg; Ochniewicz, Piotr; Zedenius, Jan; Bernhardt, Peter; Frejd, Fredrik Y; Nestor, Marika

Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules

放射性金属螯合物对使用放射性标记的亲和体分子进行体内免疫检查点蛋白可视化的影响

Tolmachev, Vladimir; Papalanis, Eleftherios; Bezverkhniaia, Ekaterina A; Rosly, Alia Hani; Vorobyeva, Anzhelika; Orlova, Anna; Carlqvist, Matilda; Frejd, Fredrik Y; Oroujeni, Maryam

Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

利用镓-68标记的Affibody分子进行B7-H3表达的临床前正电子发射断层扫描成像

Tolmachev, Vladimir; Bezverkhniaia, Ekaterina A; Papalanis, Eleftherios; Muhammad, Abdullah Mujahid Bin; Vorobyeva, Anzhelika; Gunneriusson, Elin; Klint, Susanne; Ryer, Eva; Carlqvist, Matilda; Kazmierczak, Wojciech; Orlova, Anna; Frejd, Fredrik Y; Oroujeni, Maryam

PET imaging of platelet derived growth factor receptor β in lung fibrosis

肺纤维化中血小板衍生生长因子受体β的PET成像

Wegrzyniak, Olivia; Lechi, Francesco; Rokka, Johanna; Mitran, Bogdan; Zhang, Bo; Thelander, Ulrika; Löfblom, John; Frejd, Fredrik Y; Korsgren, Olle; Perchiazzi, Gaetano; Eriksson, Jonas; Eriksson, Olof

PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation.

PDGFRß靶向正电子发射断层扫描作为活化肝星状细胞的非侵入性生物标志物:临床转化前的最后步骤。

Yashaswini Chittampalli N, Mitran Bogdan, Papadopoulos Natalia, Wegrzyniak Olivia, Löfblom John, Nordström Helena, Velikyan Irina, Abouzayed Ayman, Johansson Lars, Hagmar Per, Wagner Michael, Frejd Fredrik Y, Korsgren Olle, Heldin Carl-Henrik, Friedman Scott L, Eriksson Olof

Evaluation of a novel (177)Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile

对一种新型的(177)Lu标记的治疗性Affibody分子进行评估,该分子具有去免疫化的ABD结构域和改进的生物分布特征。

Liu, Yongsheng; Oroujeni, Maryam; Liao, Yunqi; Vorobyeva, Anzhelika; Bodenko, Vitalina; Orlova, Anna; Konijnenberg, Mark; Carlqvist, Matilda; Wahlberg, Elisabet; Loftenius, Annika; Frejd, Fredrik Y; Tolmachev, Vladimir

Non-invasive PET imaging of liver fibrogenesis using a RESCA-conjugated Affibody molecule

使用 RESCA 结合 Affibody 分子对肝纤维化进行无创 PET 成像

Olivia Wegrzyniak, Francesco Lechi, Bogdan Mitran, Pierre Cheung, Athanasios Bitzios, Jonas Persson, John Löfblom, Helena Nordström, Jonas Eriksson, Fredrik Y Frejd, Olle Korsgren, Bo Zhang, Olof Eriksson